UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 217

Sortiert nach

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4664-5, Article 4664

2018

Volltextzugriff (PDF)

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.81-89

2021

Volltextzugriff (PDF)

Molecular sputum analysis for the diagnosis of lung cancer

British journal of cancer, 2013-08, Vol.109 (3), p.530-537

2013

Volltextzugriff (PDF)

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

Annals of oncology, 2017-11, Vol.28 (11), p.2725-2732

2017

Volltextzugriff (PDF)

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.179-186

2019

Volltextzugriff (PDF)

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

British journal of cancer, 2016-12, Vol.115 (12), p.1504-1512

2016

Volltextzugriff (PDF)

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S91-S92

Thunnissen, E.

2021

Volltextzugriff (PDF)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

British journal of cancer, 2015-03, Vol.112 (6), p.1105-1113

2015

Volltextzugriff (PDF)

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Lung cancer (Amsterdam, Netherlands), 2019-12, Vol.138, p.102-108

2019

Volltextzugriff (PDF)

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S985

2021

Volltextzugriff (PDF)

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Annals of oncology, 2012-12, Vol.23 (12), p.3188-3189

2012

Volltextzugriff (PDF)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

British journal of cancer, 2014-07, Vol.111 (2), p.413-420

2014

Volltextzugriff (PDF)

Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung

Medicina oral, patología oral y cirugía bucal, 2015-01, Vol.20 (1), p.e30-e33

2015

Volltextzugriff (PDF)

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1633-S1634

Thunnissen, E.

2017

Volltextzugriff (PDF)

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii49-viii49

2018

Volltextzugriff (PDF)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

The New England journal of medicine, 2020-02, Vol.382 (6), p.503-513

2020

Volltextzugriff (PDF)

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S325-S325

2018

Volltextzugriff (PDF)

Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome

Lung, 2014-02, Vol.192 (1), p.215-216

2014

Volltextzugriff (PDF)

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S87-S88

2022

Volltextzugriff (PDF)

Guidance for laboratories performing molecular pathology for cancer patients

Journal of clinical pathology, 2014-11, Vol.67 (11), p.923-931

2014

Volltextzugriff (PDF)

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.985-989

2015

Volltextzugriff (PDF)

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Virchows Archiv : an international journal of pathology, 2012-09, Vol.461 (3), p.245-257

2012

Volltextzugriff (PDF)

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S971-S971

2021

Volltextzugriff (PDF)

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Strahlentherapie und Onkologie, 2014-02, Vol.190 (2), p.204-209

2014

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Molecular sputum analysis for the diagnosis of lung cancer

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Guidance for laboratories performing molecular pathology for cancer patients

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Aktive Filter

Suchergebnisse filtern